Acceptable medication non-adherence: A crowdsourcing study among French physicians for commonly prescribed medications

Abstract

BackgroundAchieving good medication adherence is a major challenge for patients with chronic conditions. Our study aimed to assess the Threshold for Unacceptable Risk of Non-adherence (TURN), defined as the threshold at which physicians consider the health risks incurred by patients due to medication non-adherence unacceptable, for the most commonly prescribed drugs in France.MethodsWe conducted an online study using a crowdsourcing approach among French general practitioners and specialists from September 2016 to August 2017. Physicians assessed the TURN for various levels of missed doses by evaluating a series of randomly presented clinical vignettes, each presenting a given medication with a given therapeutic indication. For each “drug-indication group” (i.e., all drugs from the same pharmacological class with a similar therapeutic indication): 1) we described the distribution of physicians’ assessments, 2) we provided a summary estimate of the TURN, defined as the frequency of missed doses above which 75% of the physicians’ assessments were located; 3) we computed the number of pill boxes reimbursed in France in 2016 to put our results into context.ResultsWe collected a total of 5365 assessments from 544 physicians, each of whom evaluated a random sample among 528 distinct clinical vignettes. Estimates of the TURN varied widely across drug-indication groups, ranging from risk considered unacceptable with 1 daily dose missed per month (e.g., insulin for diabetes) to risk always considered acceptable (e.g., anti-dementia drugs). Drugs with an estimated TURN of over one missing daily dose per week represented 44.9% of the prescription volume of the medications assessed in our study.ConclusionsAccording to physicians, the impact of non-adherence may vary greatly. Patient-physician discussions on the variable consequences of non-adherence could lead to a paradigm shift by seeking to reach “optimal adherence” depending on drugs rather than unrealistic “perfect adherence” to all drugs.

Exploring variables associated with medication non-adherence in patients with type 2 diabetes mellitus

“…These variations in reported adherence levels between different studies may be attributed to differences in methodologies (i.e., questionnaires used) and sample characteristics. The threshold for acceptable medication non-adherence among diabetic patients is yet to determine, but a French crowdsourcing study reported that according to medical doctors’ opinions, one daily missed dose per month of insulin therapy is considered unacceptable [ 30 ]. Therefore, in addition to poor adherence, moderate adherence among diabetic patients also should be improved.…”

Measuring Medication Adherence in Parkinson's Disease: A Systematic Review of Contributing Components in Rating Scales

“…We conducted the systematic review according to Preferred Reporting Items for Systemic Reviews and Meta-Analyses 12…”

Adherence in Hepatitis C Virus Treatment: What We Know

“…[7] Medication forgiveness is the property of a treatment regimen to maintain its efficacy despite the omission of 1 or more consecutive doses. [11] While an unforgiving drug will lose efficacy as soon as a patient deviates from their dosing regimen, a more forgiving drug may still elicit a response despite nonadherence.…”